|
C18ORF21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.602500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.558900E-04 |
| Normal-vs-Stage2 |
1.699550E-02 |
| Normal-vs-Stage3 |
2.858000E-01 |
| Normal-vs-Stage4 |
1.099340E-03 |
| Stage1-vs-Stage2 |
8.630800E-01 |
| Stage1-vs-Stage3 |
2.531400E-01 |
| Stage1-vs-Stage4 |
3.679800E-01 |
| Stage2-vs-Stage3 |
3.566000E-01 |
| Stage2-vs-Stage4 |
4.549200E-01 |
| Stage3-vs-Stage4 |
1.846400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.625300E-04 |
| Normal-vs-AfricanAmerican |
4.081600E-03 |
| Normal-vs-Asian |
1.876430E-01 |
| Caucasian-vs-AfricanAmerican |
7.265400E-01 |
| Caucasian-vs-Asian |
5.092200E-01 |
| AfricanAmerican-vs-Asian |
6.093400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.236000E-03 |
| Normal-vs-Female |
2.792800E-04 |
| Male-vs-Female |
1.935180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.53190000000381E-05 |
| Normal-vs-Extreme_Weight |
6.658000E-03 |
| Normal-vs-Obese |
9.922300E-03 |
| Normal-vs-Extreme_Obese |
2.856400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.021500E-02 |
| Normal_Weight-vs-Obese |
4.295700E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.083600E-01 |
| Extreme_Weight-vs-Obese |
9.005400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.713000E-01 |
| Obese-vs-Extreme_Obese |
8.308200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.239900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.579060E-04 |
| Normal-vs-Age(61-80Yrs) |
7.824400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.225600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.864600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.406600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.491800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.794420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.383600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.730800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.616900E-04 |
| Normal-VS-Type2 PRCC |
2.545600E-02 |
| Normal-VS-KIRP CIMP |
4.170800E-01 |
| Normal-VS-Unclassified PRCC |
2.743400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.973400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.489000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.840610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.659600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.558200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.969200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.595800E-03 |
| Normal-vs-N1 |
4.532300E-02 |
| Normal-vs-N2 |
1.620570E-01 |
| N0-vs-N1 |
8.327000E-01 |
| N0-vs-N2 |
9.489800E-01 |
| N1-vs-N2 |
8.817200E-01 |
|
|
